Last update 17 Jul 2026

NIB-101

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
NIB 101, NIB101
Target
GM2(ganglioside M2)
Action
modulators
Mechanism
GM2(ganglioside M2) modulators(GM2(ganglioside M2) modulators), Immunologic cytotoxicity
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
MesotheliomaSmall Cell Lung Cancer
Inactive Indication
Advanced Malignant Solid Neoplasm
Originator Organization
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
Active Organization
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NIB-101
NCT05192174
/ TerminatedPhase 1
An Open-Label Non-Randomized Phase 1 Dose Escalation and Dose Expansion Study of NIB101 in Participants With Advanced Solid Tumors
100 Clinical Results associated with NIB-101
Login to view more data
100 Translational Medicine associated with NIB-101
Login to view more data
100 Patents (Medical) associated with NIB-101
Login to view more data
100 Deals associated with NIB-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
24 Jan 2022
MesotheliomaPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
-
Small Cell Lung CancerPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free